• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS RX25RE OX W RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS RX25RE OX W RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3ZZ*RX25RE
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Blood Loss (2597)
Event Date 07/12/2017
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).Results: results pending completion of evaluation.Conclusions: conclusion not yet available-evaluation in progress.
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the unit failed, it was not oxygenating.The blood did not turn into red after 8 minutes on bypass.The patient was stable pre-cpb and the color of the venous blood coming from the patient at the initiation of bypass was normal, not very dark.They went on bypass and the arterial blood didn't not turn bright red as usually seen after initiation of cpb.Initially they had the fio2 at 80% and increased it to 100%.They checked all the oxygen line connections then bypassed the vaporizer and checked to see if gas was flowing out of the oxygen line to the oxygenator and there was gas flow.They connected an e-cylinder of oxygen directly to the oxygenator and the blood still did not turn red.They then made the decision to transfuse the blood from the reservoir to the patient, had anesthesia ventilate and came off bypass.The patient was hemodynamically stable and able to support himself while the clinician(s) cut a new oxygenator into a bypass line they have in their cpb circuit around the oxygenator.The account decided to put a bypass loop around the oxygenator in the event that they had to change out an oxygenator in the future.They inserted the replacement oxygenator into the bypass loop and that is why there was only about 50 ml of blood loss.There was no sequela to the patient as a result of the oxygenator event, the patient was discharged home 3-4 days postop.Blood loss of < 50 cc; product was changed out; with 6 to 7 minutes delay in the procedure; procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 07, 2017.(b)(4).The actual sample was not available for evaluation; therefore, the cause of the complaint cannot be determined.Possible cause of the deterioration in the gas transfer performance immediately after the initiation of the circulation includes the circulation flow rate was not sufficient for the patient's body surface area.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NS RX25RE OX W RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer Contact
cathleen hargreaves
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key6772205
MDR Text Key82060769
Report Number1124841-2017-00168
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K1513213
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/07/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2020
Device Model Number3ZZ*RX25RE
Device Catalogue NumberN/A
Device Lot NumberVC27 OR VD13
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/30/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/04/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-